Back to Journals » Drug Design, Development and Therapy » Volume 15
RETRACTED ARTICLE: Ventilagolin Suppresses Migration, Invasion and Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma Cells by Downregulating Pim-1
Authors Liu Y, Cheng DH, Lai KD, Su H 
, Lu GS, Wang L, Lv JH
Received 3 July 2021
Accepted for publication 11 November 2021
Published 1 December 2021 Volume 2021:15 Pages 4885—4899
DOI https://doi.org/10.2147/DDDT.S327270
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Tuo Deng
This paper has been retracted.
Liu Y, Cheng DH, Lai KD, et al. Drug Des Devel Ther. 2021;15:4885–4899.
We, the Editors and Publisher of the journal, Drug Design, Development and Therapy have retracted the published article.
After publication, concerns have been raised by a third party regarding the integrity of the data in Figure 1 and Figure 4. Further investigations conducted by the Journal and Publisher confirmed duplicate image panels between Figure 1 and Figure 4 which are representative of different treatment conditions.
When approached for an explanation, the authors responded. However, further data integrity concerns were identified in the original Western blot data provided. As verifying the validity of published work is core to the integrity of the scholarly record, we are therefore retracting the article. The corresponding author listed in this publication has been informed.
We have been informed in our decision-making by our editorial policies and the COPE guidelines.
The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as ‘Retracted’.
© 2021 The Author(s). This work is published and licensed by Dove Medical Press Limited. The
full terms of this license are available at https://www.dovepress.com/terms
and incorporate the Creative Commons Attribution
- Non Commercial (unported, 3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted
without any further permission from Dove Medical Press Limited, provided the work is properly
attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.